Clinical Trial Update: Phase 2b Controlled Study of Dosing Techniques - Part B [Phase 2]

View source ↗

Summary

Phase 2b, Part B controlled study evaluating dosing techniques for dry eye has completed enrollment and status is marked COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Snippet

Sponsor: IVIEW Therapeutics Inc. | Conditions: Dry Eye | Phase 2 | Status: COMPLETED